Status:
COMPLETED
The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Fever
Reduction in Temperature
Eligibility:
All Genders
14-75 years
Phase:
NA
Brief Summary
A randomized clinical trial to check the antipyretic efficacy of oral and intravenous paracetamol and intramuscular diclofenac sodium in patients presenting with fever to emergency department.
Eligibility Criteria
Inclusion
- Adults between the age of 14-75 years with an oral temperature of more than 38.5 C
Exclusion
- History of allergy to any of the drugs in the study
- Had taken antipyretics within 8 hours
- Renal, hepatic or haematological disorders
- bronchial asthma, peptic ulcer disease, vomiting
- Pregnant or lactating women
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
434 Patients enrolled
Trial Details
Trial ID
NCT01891435
Start Date
January 1 2010
End Date
April 1 2013
Last Update
July 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad medical corporation
Doha, Qatar, 3050